CanSino Biologics Inc.
CASBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,207 | $5,165 | $14,246 | $36,152 |
| - Cash | $1,556 | $2,047 | $3,395 | $5,457 |
| + Debt | $2,013 | $2,700 | $2,701 | $1,375 |
| Enterprise Value | $7,664 | $5,819 | $13,552 | $32,070 |
| Revenue | $825 | $345 | $1,031 | $4,300 |
| % Growth | 139% | -66.5% | -76% | – |
| Gross Profit | $580 | -$876 | -$187 | $3,003 |
| % Margin | 70.4% | -253.8% | -18.1% | 69.8% |
| EBITDA | -$110 | -$1,646 | -$1,319 | $1,849 |
| % Margin | -13.3% | -476.8% | -127.9% | 43% |
| Net Income | -$379 | -$1,483 | -$909 | $1,914 |
| % Margin | -45.9% | -429.6% | -88.2% | 44.5% |
| EPS Diluted | -1.53 | -6.01 | -3.69 | 7.74 |
| % Growth | 74.5% | -62.9% | -147.7% | – |
| Operating Cash Flow | -$169 | -$916 | -$1,888 | $2,015 |
| Capital Expenditures | -$458 | -$610 | -$1,075 | -$1,203 |
| Free Cash Flow | -$626 | -$1,527 | -$2,963 | $811 |